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Components of cytoplasmic processing bodies (P-bodies) and stress granules can be subverted during
viral infections to modulate viral gene expression. Because hepatitis C virus (HCV) RNA abundance is
regulated by P-body components such as microRNA miR-122, Argonaute 2 and RNA helicase RCK/p54,
we examined whether HCV infection modulates P-bodies and stress granules during viral infection. It
was discovered that HCV infection decreased the number of P-bodies, but induced the formation of
stress granules. Immunoﬂuorescence studies revealed that a number of P-body and stress granule
proteins co-localized with viral core protein at lipid droplets, the sites for viral RNA packaging.
Depletion of selected P-body proteins decreased overall HCV RNA and virion abundance. Depletion of
stress granule proteins also decreased overall HCV RNA abundance, but surprisingly enhanced the
accumulation of infectious, extracellular virus. These data argue that HCV subverts P-body and stress
granule components to aid in viral gene expression at particular sites in the cytoplasm.
& 2012 Elsevier Inc. All rights reserved.Introduction
Individuals chronically infected with Hepatitis C virus (HCV) are
at risk to develop liver cirrhosis and hepatocellular carcinoma (Seeff,
2009). Unfortunately, treatments directed against HCV are limited
and a protective vaccine is not available. Thus, an understanding of
the HCV lifecycle and virus–host interactions is crucial for the
development of new strategies that target HCV. HCV is an enveloped
RNA virus of the Flaviviridae family (Lindenbach and Rice, 2001). The
9.6 kb single-stranded positive-sense genome contains conserved 50
and 30 untranslated regions (UTRs), and a single open reading frame
that is translated by an internal ribosome entry site mechanism to
yield 10 viral proteins: core, envelope glycoprotein 1 (E1), E2, p7,
nonstructural protein 2 (NS2), NS3, NS4A, NS4B, NS5A and NS5B.
The viral NS proteins direct replication of the HCV genome and also
participate in the assembly of viral particles on lipid droplets
(reviewed in (Bartenschlager et al., 2011). The assembled viral
particles contain the structural proteins core, E1 and E2. To maintain
viral RNA abundance in the infected liver, HCV RNA forms a speciﬁc
interaction with the liver-speciﬁc microRNA miR-122 at two sites
within the 5’ UTR (Jopling et al., 2005, 2008; Machlin et al., 2011).
This oligomeric RNA complex enhances HCV RNA stability (Normanll rights reserved.
of Medicine, Department of
uilding, D309 299, Campus
).and Sarnow, 2010), and its anatomy and intracellular localization is
under intense scrutiny.
The stability of both cellular and viral RNAs can be modulated in
speciﬁc cytoplasmic granular structures, known as processing
bodies (P-bodies) and stress granules. P-bodies are discrete cyto-
plasmic foci where nontranslating mRNAs are either decapped and
degraded (Cougot et al., 2004; Sheth and Parker, 2003). Additionally,
some mRNAs may be stored in P-bodies and later returned to the
cytoplasm as translation-competent mRNAs (Brengues et al., 2005).
However, this model has recently been challenged (Arribere et al.,
2011). P-bodies are constitutively present in cells, although their
number and size depend on the abundance of RNAs sequestered for
storage and turnover (Cougot et al., 2004). Components of P-bodies
include mRNAs, the decapping enzyme complex Dcp1–Dcp2
(van Dijk et al., 2002), the 50–30 exoribonuclease Xrn1 (Ingelﬁnger
et al., 2002), mRNA deadenylase CCR4, activators of decapping such
as Lsm1-7 proteins, DEAD-box helicase RCK/p54 (also known as
DDX6), RNA-associated protein 55 (RAP55), hEDC3, and Ge-1
(reviewed in Eulalio, 2007 #137). The ﬁnding that Argonaute
proteins, microRNAs and microRNA-targeted mRNAs reside in
P-bodies as well, argues for a role for P-bodies in microRNA-
directed gene regulation (Bhattacharyya et al., 2006; Liu et al.,
2005; Pauley et al., 2006; Pillai et al., 2005).
Interestingly, P-bodies often reside next to stress granules,
which store a subset of cellular mRNAs that are translationally
arrested in response to environmental stimuli, such as oxidative
stress, nutrient deprivation or viral infections (reviewed in
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addition to the translationally stalled mRNAs, stress granules also
harbor translation initiation factors eIF2, eIF3, eIF4A, eIF4E and
eIF4G, 40 S ribosomal subunits, and poly(A) binding protein
(Kedersha and Anderson, 2007). Furthermore, proteins such as
T-cell restricted intracellular antigen-1 (TIA-1), TIA-1 related
protein (TIAR), the RasGAP-associated endonuclease G3BP1
(Tourriere et al., 2003), ubiquitin-speciﬁc processing protease 10
(USP10) (Soncini et al., 2001), Caprin1 (Solomon et al., 2007),
OGFOD1 (Wehner et al., 2010) and Argonaute proteins (Leung
et al., 2006) are also recruited to stress granules.
To investigate the role of P-body and stress granule constitu-
ents in the HCV infectious cycle, we examined the fates of P-
bodies and stress granules during HCV infection. The formation of
stress granules and dramatic changes in P-body number was
observed upon viral infection; and depletion of selected P-body
and stress granule proteins greatly affected the abundance of HCV
RNA, proteins and virus particles. These ﬁndings reveal important
roles for these cytoplasmic structures in the HCV life cycle and
suggest that they can be targeted for antiviral intervention.Results
Dispersion of P-bodies following HCV infections
To examine the fate and morphology of P-bodies during HCV
infection, Huh7 cells were infected with the genotype 2 JFH-1 strainFig. 1. Dispersion of P-bodies during JFH-1 infection. (A) Distribution of P-bodies. Huh7
uninfected and infected cells was examined by confocal microscopy. P-bodies and HCV-p
(red) or HCV NS5A (green) proteins. Representative images are shown. (B) Number of P
P-bodies was quantiﬁed using ImageJ software. Mean values and standard deviati
(C) Abundances of P-body proteins (RCK/p54, Lsm1, Dcp1a, Dcp2, Ge-1, Xrn1, Ago2), an
and 3 days p.i. were examined by western blot analysis. The abundance of actin serve
caption, the reader is referred to the web version of this article.)of HCV, and the distribution of P-bodies in uninfected and infected
cells was examined by confocal microscopy using antibodies directed
against the P-body protein RCK/p54. RCK/p54 localized to distinct
P-bodies in uninfected cells (Fig. 1A). However, the number of these
structures greatly diminished in JFH-1-infected cells, as identiﬁed by
NS5A-positive staining. To determine if the reduced number of
P-bodies in JFH-1-infected cells was signiﬁcant, we counted the
number of P-bodies per cell in uninfected and infected cells. The
number of P-bodies decreased by 50% in infected cells (Fig. 1B).
Interestingly, JFH-1 infection did not completely abrogate P-bodies
and similar numbers of P-bodies, albeit decreased, remained 1, 2 and
3 days post-infection (p.i.). The dispersal of P-bodies was not speciﬁc
to the fast replicating genotype 2 JFH-1 virus, because electroporation
of infectious genotype 1 H77c RNA dispersed P-bodies as well
(Fig. S1A). P-bodies were also dispersed following electroporation of
a genotype 1 replicon RNA (H77DE1/p7) that lacks the viral envelope
and p7 genes, and does not give rise to infectious particles but
undergoes RNA replication (Fig. S1A). These ﬁndings suggest that
dispersion of P-bodies does not require virus–receptor interactions,
viral packaging or the formation of infectious particles. Furthermore,
proteins required for viral mRNA translation and RNA replication are
sufﬁcient to accomplish the dispersal of P-bodies.Effects of HCV infection on the abundance of P-body proteins
To determine whether P-body dispersion after JFH-1 infection
affected the abundance or integrity of speciﬁc P-body proteins,cells were infected with JFH-1 virus and 3 days p.i., the distribution of P-bodies in
ositive cells were identiﬁed by staining with speciﬁc antibodies detecting RCK/p54
-bodies in uninfected and JFH-1-infected cells 1, 2, and 3 days p.i. The number of
ons of four independent experiments are shown, ***Po0.001 and **Po0.002.
d viral NS5A and core proteins in JFH-1 infected and uninfected Huh7 cells at 1, 2,
s as a loading control. (For interpretation of the references to color in this ﬁgure
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uninfected or JFH-1-infected cells. Kinetic analysis showed that
neither the abundance nor molecular weights of P-body proteins
RCK/p54, Lsm1, Dcp1a, Dcp2, Ge-1, Xrn1 or Ago2 changed during
infection with JFH-1 (Fig. 1C). These data argue that the dispersal
of P-bodies during viral infection does not result from a change in
the abundance of the examined P-body proteins. Given that P-
bodies are known to be involved in many aspects of microRNA
function in the cytoplasm, we also examined the abundance of
miR-122 at early (1 or 2 days) or late (3 days) times after viral
infections (Fig. S1B). No differences in miR-122 abundances were
observed, arguing that P-body dispersion does not affect miR-122
turnover or synthesis during HCV infection.Fig. 2. Localization of RCK/p54, core and lipid droplets during JFH-1 infection. (A) Locali
RCK/p54, HCV core and lipid droplets in JFH-1 infected Huh7 cells 3 days p.i. Bodipy 493
confocal microscope. RCK/p54 (B, D) and HCV core (B) in the representative image have
quantifying the degree of co-localization is presented in the merged images.Localization of viral core protein with the P-body protein RCK/p54
and lipid droplets
To examine whether HCV interacts with some or all dispersed
P-body proteins, the localization of viral core with several P-body
proteins was determined by confocal microscopy 3 days after virus
infection. Co-localization of proteins was quantitated by determina-
tion of Pearson’s correlation coefﬁcient (Adler and Parmryd, 2010)
(see Materials and methods section). This analysis showed that HCV
core partially localized with P-body proteins RCK/p54 (Fig. 2B), Lsm1,
Dcp2 and Xrn1 (Fig. S2) in infected cells. It is known that HCV core
protein localizes to lipid droplets that accumulate in infected cells
(Fig. 2C) (Barba et al., 1997; Miyanari et al., 2007). Therefore,zation of RCK/p54 and lipid droplets in uninfected Huh7 cells. (B–D) Localization of
/503 was used to stain lipid droplets, and images were acquired with a Zeiss LSM5
been re-colored image to show co-localization. Pearson’s correlation coefﬁcient (r)
Fig. 3. Effects of depletion of P-body proteins on JFH-1 protein and RNA abundances.
Huh7 cells were depleted of P-body proteins and infected with JFH-1 virus.
(A) Abundances of HCV NS5A and core proteins, and P-body proteins RCK/p54, Lsm1,
Dcp2, Ge-1, Xrn1, Ago2, GW182, Upf1 and Exo10 during JFH-1 infection were
examined by western blot analysis. Transfection reagent alone (no siRNA) and the
transfection of a RISC-free siRNA were included as controls. (B) Abundances of HCV
RNA and miR-122. Representative northern blots are shown. Actin mRNA and U6
snRNA were used as RNA loading controls. (C) Quantitation of HCV RNA. HCV RNA
abundances were normalized to actin mRNA and to control RISC-free siRNA. Mean
values and standard deviations from three independent experiments are shown.
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lipid droplets during viral infection. Indeed, RCK/p54 partially loca-
lized to lipid droplets in infected cells (Figs. 2D and S2), but not inuninfected cells (Fig. 2A). The co-localization of RCK/p54 with core
and lipid droplets was similar to diglyceride acyltransferase-1
(DGAT-1; Fig. S2), a protein known to facilitate core-mediated virion
assembly at lipid droplets (Herker et al., 2010). These ﬁndings show
that JFH-1 infection directs the redistribution of the P-body proteins
such as RCK/p54 and Lsm1 to a complex that harbors viral core
protein, cellular lipid droplets and DGAT-1. In contrast, none of the
P-body proteins examined co-localized with viral dsRNA or the
replication protein NS5A (data not shown).
Decrease of HCV RNA and protein abundances after siRNA-mediated
depletion of certain P-body proteins
To examine the effect of P-body protein abundances on JFH-1 gene
expression, the abundances of nine different P-body proteins were
reduced using siRNAs. Western blot analyses showed that each
P-body protein could be effectively depleted (Fig. 3A). While siRNA-
mediated depletion of many P-body proteins slightly decreased HCV
protein (Fig. 3A) and RNA abundances (Fig. 3B), depletion of Lsm1,
Ge-1, Ago2, and in particular RCK/p54, strongly decreased the
abundance viral RNA and proteins (Fig. 3A–C). In contrast, the
depletion of P-body proteins did not change the abundance of cellular
actin, miR-122 or U6 RNAs (Figs. 3B and S3A). These ﬁndings argue
that HCV RNA abundance is enhanced by the presence of P-body
proteins RCK/p54, Lsm1, Ge-1 and Ago2.
Formation of stress granules during HCV infection
It is known that stress granules accumulate adjacent to P-bodies
during oxidative stress (Kedersha et al., 2005). To examine whether
uninfected Huh7 cells form stress granules in response to oxidative
stress, cells were incubated without or with 1 mM arsenite. As shown
in Fig. 4A, the addition of arsenite induces the formation of punctuate,
eIF3Z-containing stress granules in the cytoplasm. Similarly, infection
of Huh7 cells with JFH-1 virus resulted in the formation of eIF3- and
TIA-1-positive stress granules (Fig. 4A, and data not shown). Quanti-
tation showed that, in contrast to uninfected cells, the formation of
stress granules in infected cells increased during infection (Fig. 4B).
Oxidative cell stress and stress granule formation is usually accom-
panied by the phosphorylation of eIF2a. This event blocks transla-
tional initiation and shuttles untranslated mRNAs and 40S ribososmal
subunits to newly formed stress granules (Anderson and Kedersha,
2009a; Kedersha and Anderson, 2002; Kedersha et al., 2005).
To determine whether JFH-1 infection affected the phosphorylation
status of eIF2a, the phosphorylation status of eIF2a was examined at
different times after infection. Surprisingly, by western blot analysis
eIF2a was not phosphorylated, and immunoﬂuorescence studies
showed that the localization of phosphorylated eIF2a did not change
in JFH-1-infected Huh7 cells (Fig. S4 and data not shown). However,
JFH-1 did not inhibit the phosphorylation of eIF2a or the formation of
new stress granules following arsenite treatment (data not shown).
Thus, JFH-1-induced stress granule formation in Huh7 cells can occur
by a mechanism requires little phosphorylation of eIF2a. The
abundances of six stress granule proteins remained unchanged during
JFH-1 infection (Fig. 4C). Therefore, the formation of stress granules
during HCV infection was not a result of enhanced intracellular
abundance of the examined stress granule proteins. Instead, stress
granule formation during HCV infection most likely reﬂects a
localized concentration of stress granule proteins.
A number of RNA binding proteins, as well as components of
the translation initiation complex localize in stress granules.
Components of stress granules in JFH-1 infected cells were
examined by confocal microscopy. G3BP1, TIA-1, TIAR, USP10,
OGFOD1, and RpS6 co-localized in virus-induced stress granules
(Fig. S5 and data not shown). Furthermore, during arsenite-
induced stress P-bodies often localize adjacent to stress granules
Fig. 4. Formation of stress granules during JFH-1 infection. (A) Induction of stress granules by arsenite and JFH-1 infection. Uninfected and JFH-1 infected Huh7 cells were
treated without or with 1 mM arsenite for 30 min at 37 1C. Cells were ﬁxed and stained with eIF3Z (red) and HCV NS5A (green) speciﬁc antibodies. Representative confocal
microscopy images are presented. White arrows point to examples of stress granules. (B) Induction of stress granules during JFH-1 infection 1, 2 and 3 days p.i.
The appearance of stress granules in uninfected and JFH-1-infected Huh7 cells was quantiﬁed using ImageJ software. Mean values and standard deviations of three
independent experiments are shown. (C) Abundances of NS5A, core, and stress granule proteins (TIA-1, TIAR, G3BP1, HuR, Ataxin2, and YB-1) from JFH-1 infected and
uninfected Huh7 cells at 1, 2, and 3 days p.i. were examined by western blot analysis. Abundance of GAPDH serves as a control. (For interpretation of the references to color
in this ﬁgure caption, the reader is referred to the web version of this article.)
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containing P-bodies were found adjacent to and co-localized with
G3BP1, TIA-1 and TIAR-containing stress granules (data not
shown), indicating that the cytoplasmic granules formed in JFH-1
infected cells are bona ﬁde stress granules.
Localization of stress granule proteins, HCV core and lipid droplets in
JFH-1-infected cells
To examine whether HCV core protein co-localized with stress
granule proteins, uninfected and HCV-infected cells were ﬁxed and
the localization of core, lipid droplets and G3BP1, TIA-1, TIAR, USP10
and OGFOD1 was examined by confocal microscopy. In uninfected
cells G3BP1 and USP10 were distributed throughout the cytoplasm,
while TIA-1, TIAR and OGFOD1 were predominantly nuclear (data not
shown). During JFH-1 infection G3BP1, TIA-1, TIAR, USP10, OGFOD1
and S6 localized with core-containing foci (Figs. 5 and S2 and data not
shown). However, co-localization analysis shows that only G3BP1
and USP10 partially colocalized with core and lipid droplets (Figs. 5
and S2). In contrast, these stress granule proteins rarely localized
with NS5A and viral dsRNA (Fig. S5 and data not shown). Thus, in
JFH-1 infected cells, both P-body and stress granule proteins redis-
tribute to granular foci that speciﬁcally co-localize with core and
lipid droplets.
Diminished HCV protein and RNA abundances following
siRNA-directed depletion of stress granule proteins
To examine the role of several proteins that are unique to stress
granules in HCV gene expression, TIA-1, G3BP1, HuR, Ataxin2, USP10
and OGFOD1 were depleted by siRNA-mediated mRNA degradation.
Western blot analysis showed that each examined stress granuleprotein was effectively depleted (Fig. 6A). While depletion of each
stress granule protein decreased the abundance of viral core and
NS5A proteins, concomitant with a decrease in viral RNA (Fig. 6B
and C), depletion of HuR and USP10 in particular decreased the
abundance of viral RNA and protein. Similar to what was observed
after depletion of P-body proteins, depletion of the examined stress
granule proteins did not affect miR-122 abundance (Fig. S3B).
Overall, these co-localization studies suggest that stress granule
and P-body proteins modulate HCV RNA abundance by a mechan-
ism that may involve viral core protein and cellular lipid droplets.
Localization of ectopically expressed HCV core protein
To examine whether core localizes to P-body and stress granule
proteins in the absence of viral infection, Huh7 cells were transfected
with control plasmid or with a plasmid that encoded the core gene.
Fig. 7 shows that ectopically expressed core localized mainly to lipid
droplets. Interestingly, RCK/p54-containing P-body foci were not
signiﬁcantly dispersed and did not co-localize with core at lipid
droplets in core-expressing cells (Fig. 7). Similarly, G3BP1 did not
show co-localization with ectopically expressed core protein (Fig. 7).
These data show that the expression of core protein in the absence of
a viral infection is not sufﬁcient to disperse P-bodies or alter the
localization of RCK/p54 and G3BP1, arguing that other viral factors
might contribute to the re-localization of P-body and stress granule
proteins.
Enhancement of extracellular virion accumulation following
depletion of G3BP1
That lipid droplets and core protein co-localize with stress
granule and P-body proteins suggest that these proteins might
Fig. 5. Localization of core, lipid droplets and stress granule proteins in JFH-1 infected cells. Localization of HCV core, lipid droplets and stress granule proteins (G3BP1,
TIA-1 and USP10) in JFH-1 infected Huh7 cells was examined. Bodipy 493/503 was used to stain lipid droplets, and images were acquired with a Zeiss LSM5 confocal
microscope. Representative images show the staining of HCV core (black and white), and co-staining of lipid droplets (green) and individual stress granule proteins (red).
Pearson’s correlation coefﬁcient (r) quantifying the degree of co-localization between lipid droplets (Bodipy 493/503) and stress granules proteins is presented in the
merged images. (For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this article.)
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the effect of depleting selected P-body and stress granule proteins
on HCV virion production was examined. Depletion of RCK/p54,
Ge-1, HuR, Ataxin2 and USP10 decreased the titer of both cell-
associated (Fig. 8A) and extracellular virions (Fig. 8B), as well as
the abundance of intracellular core protein (Fig. 8C). Curiously,
depletion of USP10 increased the abundance of extracellular core
protein (Fig. 8D). Depletion of TIA-1 and OGFOD1 decreased both
viral protein and RNA abundances (Fig. 5) yet virus titer was not
affected (Fig. 8A and B). Interestingly depletion of G3BP1
decreased cell-associated virus titer (Fig. 8A) but increased
extracellular titer at least three-fold (Fig. 8B), without any
increase in the extracellular abundance of core protein (Fig. 8D),
suggesting that the normal function of G3BP1 is to suppress the
production of infectious extracellular virus, and that stress gran-
ule proteins function at a late step in the HCV infectious cycle.Discussion
In this study we show that HCV dispersed P-body foci not by
degrading P-body proteins, but likely by modulating the intracel-
lular distribution of these proteins to HCV core protein associated
with lipid droplets. Additionally, HCV infection induced the
formation of stress granules independent of eIF2a phosphoryla-
tion. Stress granule proteins similarly localized with core protein
at lipid droplets during HCV infection. Overexpression and loca-
lization of core alone did not induce the re-localization of P-body
and stress granule proteins to lipid droplets. Additionally RNAi-
mediated depletion of speciﬁc P-body and stress granule proteinsdecreased the expression of HCV proteins and RNA, and modu-
lated virion assembly and release.
During HCV infection we observed that RCK/p54, Lsm1, Xrn1
and GW182-containing P-bodies were dispersed (Figs. 1A and S1
and data not shown). Similarly, early during poliovirus infection
P-body foci are dispersed and the exoribonuclease Xrn1, decap-
ping factor Dcp1a and deadenylase protein Pan3 are rapidly
degraded (Dougherty et al., 2011). Unlike poliovirus, however,
HCV did not induce degradation or modiﬁcation of P-body
proteins (Fig. 1C). Interestingly, West Nile and Dengue viruses
also disperse P-body foci late during infection; however, the
mechanism by which this occurs is unknown (Emara and
Brinton, 2007). We speculated that HCV might disperse P-bodies
by modulating the intracellular distribution of P-body compo-
nents. For example, re-localization of potentially deleterious
components such as the exoribonuclease Xrn1 and the decapping
enzyme Dcp2 might limit the degradation of viral genomes.
Similar to Scheller et al. (2009), however, we ﬁnd that depletion
of Xrn1 and Dcp2 only modestly decreased HCV gene expression,
and thus they seem unlikely to affect HCV RNA stability. Alter-
natively, HCV might sequester key components that are essential
to modulate viral gene expression. MiR-122 resides in P-bodies
(Bhattacharyya et al., 2006) and is critical to maintaining HCV
RNA abundance (Jopling et al., 2005, 2008). While we cannot
exclude the possibility that HCV re-localizes miR-122-containing
RISC complexes from P-bodies, sequestration of miR-122 with
antisense locked nucleic acid oligonucleotides did not disperse P-
bodies (data not shown). However, depleting components of the
decapping and RISC complexes, speciﬁcally RCK/p54, Lsm1, Ge-1
and Ago2, signiﬁcantly decreased HCV protein and RNA abun-
dances (Fig. 3). Scheller et al. (2009) demonstrated that HCV 50
Fig. 6. Effects of depletion of stress granule proteins on JFH-1 protein and
RNA abundances. (A) Abundances of stress granule proteins TIA-1, G3BP1,
HuR, Ataxin2, USP10 and OGFOD1, and viral NS5A and core after siRNA-mediated
depletion of stress granule proteins and JFH-1 infection. Western blots are
shown. Transfection reagent alone (no siRNA) and the transfection of a
RISC-free siRNA were included as controls. The abundance of GAPDH serves as a
loading control. (B) Abundances of HCV RNA and miR-122 during depletion of
stress granule proteins. Representative northern blots are shown. Actin mRNA and
U6 snRNA were used as RNA loading controls. (C) Quantitation of HCV RNA. HCV
RNA abundances were normalized to actin mRNA and to RISC-free siRNA.
Mean values and standard deviations from three independent experiments
are shown.
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that depletion of Lsm1 decreased viral translation without affect-
ing RNA stability (Scheller et al., 2009). A role for RCK/p54 in HCV
translation and replication has previously been proposed (Jangra
et al., 2010; Scheller et al., 2009). RCK/p54 was shown to co-
immunoprecipitate HCV RNA and cellular mRNA, but did not co-
localize with HCV dsRNA (Jangra et al., 2010). Our immunoﬂuor-
escence localization studies showed RCK/p54, Lsm1, Ge-1, Dcp2,
Xrn1 and GW182 were juxtaposed to replication sites stained for
dsRNA and NS5A (data not shown). However RCK/p54 and Lsm1
localized with core protein at lipid droplets (Figs. 2 and S2), a
ﬁnding that was also reported by (Ariumi et al. (2012). In addition
Dcp2 and Xrn1, and to a lesser extent Ge-1 and GW182, showed
similar localization with core (Fig. S2 and data not shown). That
Dcp2 localizes with core at putative assembly sites contrasts that
reported by Ariumi et al. (2012) (Fig. S2 and data not shown;
#230}. Furthermore we ﬁnd that Dcp2 localization (visualized
with three different antibodies) did not localize to large foci, but
rather in numerous tiny foci (data not shown). Although the
differences in Dcp2 might be attributed to different experimental
conditions, the localization of Dcp2 with core is unclear.
Depletion of Ge-1 decreased JFH-1 RNA and protein abun-
dances (Fig. 3), and cell-associated and extracellular virus titers
(Fig. 7), suggesting Ge-1 may function at an earlier step in
HCV gene expression to ultimately affect virion production.
Perez-Vilaro et al. (2012) showed that components localized in
P-bodies differ during HCV infection (Perez-Vilaro et al., 2012).
Indeed, in JFH-1 infected cells we observed small Ge-1-containing
foci (data not shown). This ﬁnding raises the possibility that Ge-1-
complexes localizing with core at lipid droplets may contain
different components and functions to those localized in the
cytoplasm. Interestingly, the abundance of Dcp2 also decreased
following depletion of Ge-1 (Fig. 3A). Since the siRNAs speciﬁcally
targeted Ge-1, it is unlikely that loss of Dcp2 is the result of an off-
target effect. Ge-1 is a central component of P-bodies (Yu et al.,
2005), interacts with RCK/p54 (unpublished data), bridges the
interaction between Dcp1 and Dcp2 and stimulates Dcp2 activity
in vitro (Fenger-Gron et al., 2005). As such in the absence of Ge-1,
the decapping complex may disassemble and stimulate Dcp2
turnover. Depletion of RCK/p54 decreased cell-associated and
extracellular virus titers, although the amount of core protein
released was similar in cells treated with the RISC-free siRNA
(Fig. 8). Dhh1, the yeast ortholog of RCK/p54, facilitates the re-
localization of brome mosaic virus RNA to P-bodies. Similarly in
HCV-infected cells, RCK/p54 might facilitate the localization of
viral genomes from replication to assembly sites. Recently packa-
ging of the foamy virus genome was shown to require RCK/p54
(Yu et al., 2011). Similarly, depletion of RCK/p54 might limit HCV
genome packaging and thus decrease viral titers (Fig. 8). Although
the exact role of P-body proteins localizing with core and lipid
droplets during HCV infection is elusive, HCV may therefore
disperse P-bodies by re-localizing components to virion
assembly sites.
Phosphorylation of eIF2a at serine 51 inhibits cellular protein
translation and induces the formation of stress granules
(Kedersha et al., 1999). Recently HCV was shown to induce
phosphorylation of eIF2a via activation of the RNA-dependent
protein kinase PKR, resulting in the inhibition of translation of
interferon stimulated mRNAs (Garaigorta and Chisari, 2009). We
observed that JFH-1 induces the formation of stress granules
(Fig. 4). However, eIF2a serine 51 was not phosphorylated
(Fig. S4). At 3 days p.i., the immunoﬂuorescent distribution of
phospho-eIF2awas similar in uninfected and JFH-1 infected Huh7
cells (data not shown). While Garaigorta and Chisari (2009)
infected Huh7 cells with JFH1-d183 at an moi of 5 (Garaigorta
and Chisari, 2009), we infected Huh7 cells with wild-type JFH-1 at
Fig. 7. Localization of RCK/p54, G3BP1 and over-expressed HCV core protein. Distribution of RCK/p54, G3BP1 and over-expressed core protein in Huh7 cells.
(A) Localization of lipid droplets (red) and core (green). (B) Localization of RCK/p54 (red) and core (green). (C) Localization of G3BP1 (red) and core (green).
Lipid droplets were stained with the neutral lipid dye Bodipy 493/503. Individual and merged images are shown. Images have been re-colored for presentation.
(For interpretation of the references to color in this ﬁgure caption, the reader is referred to the web version of this article.)
C.T. Pager et al. / Virology 435 (2013) 472–484 479an moi of 0.01 suggesting that the observed differences in eIF2a
phosphorylation may be attributed to different experimental
approaches. Arnaud et al. (2010) described interferon induction
through the RIG-I/MAVS pathway early during infection, and
showed immunoprecipitation of phospho-PKR and eIF2a at 15 h
p.i. However, 18 h p.i. NS3/4A expression stimulated MAVS-
cleavage which coincided with a decrease in phosphorylated
PKR and eIF2a (Arnaud et al., 2010). That eIF2a remained
unmodiﬁed in our studies might therefore be attributed to the
sensitivity of detection (by western blot analysis) and timing
(24 h p.i.).
Poliovirus infection signiﬁcantly induced G3BP1-containing
stress granules, however as infection progressed the number of
G3BP1 granules decreased (White et al., 2007). JFH-1 infection
also induced the formation of stress granules, albeit in a low
percentage of cells (Fig. 4B). Therefore, does HCV induce or limit
stress granule formation, and what are the consequences? West
Nile virus re-localized stress granule proteins TIA-1 and TIAR from
the nucleus to the cytoplasm but restricted the formation of stressgranules (Emara and Brinton, 2007). Interestingly West Nile virus
also hindered arsenite-induced stress granule formation by
attenuating eIF2a phosphorylation. JFH-1 similarly re-localized
stress granule components. In contrast, we found that arsenite
treatment induces the phosphorylation of eIF2a in JFH-1 infected
cells (data not shown), suggesting that JFH-1 does not inhibit
stress granule formation by preventing eIF2a phosphorylation.
Although the formation of TIA-1-containing stress granules was
not perturbed (Piotrowska et al., 2010), poliovirus limited the
formation of G3BP1-containing stress granules by 3C proteinase
cleavage of G3BP1 (White et al., 2007). In contrast, we observed
that the abundance and integrity of stress granule proteins did
not change during JFH-1 infection (Fig. 4C). Furthermore, JFH-1
infection does not interfere with the composition of stress
granules or localization with P-bodies (Fig. S4 and data not
shown). Similar to Ariumi et al. (2012), we ﬁnd that P-body and
stress granule proteins only localize with core protein at lipid
droplets (Figs. 2, 5 and S2), and not with endoplasmic reticulum-
associated core (data not shown; Ariumi et al., 2012). Ariumi et al.
Fig. 8. Cell-associated and extracellular infectious JFH-1 yield following depletion of RCK/p54, Ge-1, TIA-1, G3BP1, HuR, Ataxin2, USP10 and OGFOD1. Virus yield in cells
depleted of RCK/p54, Ge-1, TIA-1, G3BP1, HuR, Ataxin2, USP10 and OGFOD1 proteins. Virus yield was measured in (A) cells (cell-associated) or (B) extracellular medium
(extracellular) using the limiting dilution infectivity assay as previously described (Lindenbach et al., 2005). The transfection of a RISC-free siRNA was included as a control.
(C) Abundances of cell-associated core protein was determined by western blot analysis and ECF chemiﬂuorescence. (D) Quantitation of extracellular core proteins was
analyzed by ELISA. Mean values and standard deviations from three independent experiments are shown. HCV titer and abundance of core protein was normalized to JFH-1
infected cells transfected with the RISC-free siRNA.
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the formation of stress granules in response to heat shock and
oxidative stress. Although re-localization of stress granule com-
ponents to lipid droplets might limit the availability of compo-
nents for stress granule formation, we found that not all stress
granule components re-localize to assembly sites during JFH-1
infection (Fig. 5 and data not shown). Indeed, the number of
NS5A-positive cells with arsenite-induced eIF3Z-containing
stress granules did not differ signiﬁcantly between uninfected
and JFH-1-infected cells.
Depletion of stress granule proteins decreased the abundance of
HCV proteins and RNAs (Fig. 4), and G3BP1 and USP10 localized
with HCV core protein at lipid droplets. Interestingly, HuR, TIA-1 and
G3BP1 bind HCV RNA (Harris et al., 2006; Spangberg et al., 2000;
Tingting et al., 2006; Yi et al., 2006). Depletion of HuR and USP10
dramatically decreased virus titer. Sindbis virus and other alpha-
viruses genomes are stabilized by the binding of HuR to a U-rich
region in their 30 UTRs (Sokoloski et al., 2010). As such, the
interaction of HuR with the 30 UTR of both RNA polarities may
similarly stabilize HCV RNA (Harris et al., 2006; Spangberg et al.,
2000). Depletion of USP10 greatly decreased HCV protein and RNA
abundances and virus titers (Fig. 6, Fig. 7). USP10 modulates
anterograde and retrograde vesicular trafﬁcking (Cohen et al.,
2003a, 200 3b), the localization and stability of p53 (Yuan et al.,
2010) and binds Dengue virus RNA (Ward et al., 2011). Thus
depletion of USP10 may modulate proteosomal degradation of
proteins involved in HCV gene expression, or HCV egress. Interest-
ingly G3BP1 modulates USP10 deubiquitinase activity (Cohen et al.,
2003a), as well as interacts and co-localizes with HCV NS5B proteinand RNA to modulate HCV replication (Yi et al., 2006, 2011). Similar
to Yi et al. (2011) we observed that depletion of G3BP1 decreased
JFH-1 gene expression. In contrast however we did not observe
signiﬁcant co-localization of G3BP1 with HCV dsRNA and NS5A-
containing replication sites. Our studies and those from Ariumi et al.
(2012) show G3BP1 localizing with core protein at lipid droplets
(Figs. 6 and S2). Curiously depletion of G3BP1 increased extracellular
titers suggesting that in addition to facilitating genome replication,
G3BP1 may restrict the assembly of virions. Overexpressed core
protein and G3BP1 do not co-immunoprecipitate (Yi et al., 2011) nor
does expression of core protein alone relocalize G3BP1 to lipid
droplets (Fig. 7). The mechanism by which G3BP1 regulates virus
assembly, although unclear, likely requires an interaction with viral
RNA and/or other proteins. Reduced HCV RNA and protein abun-
dances following depletion of TIA-1, G3BP1 and OGFOD1 (Fig. 4) did
not signiﬁcantly affect cell-associated or extracellular virus titers
(Fig. 8A and B). Keum et al. (2012) recently demonstrated that virus
particles secreted early compared to late in infection differed in
infectivity and composition. Thus two possibilities may explain our
data. First, although similar amounts of extracellular core antigen
were released (Fig. 8D), the proportion of particles secreted may
contain more viral RNA in the absence of TIA-1, G3BP1 and OGFOD1.
Second, the composition of the virus particles released in the
absence of TIA-1, G3BP1 and OGFOD1 may more resemble virus
particles released early during infection namely highly infectious
particles, compared to the poorly infectious particles secreted at
later times.
Core protein associated with lipid droplets recruits the HCV
nonstructural proteins and the replication complex to lipid
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nschlager et al., 2011). Recently a number of host proteins such
as DGAT-1, Annexin A2 and YB-1 have also been shown to
facilitate HCV assembly (Backes et al., 2010; Chatel-Chaix et al.,
2011; Herker et al., 2010). Proteomic studies of lipid droplets
isolated from Huh7 cells and HepG2 cells overexpressing core
identiﬁed a number of associated proteins including Annexin A2
and DDX3, respectively (Fujimoto et al., 2004; Sato et al., 2006).
Consistent with these studies we found that overexpression of
core protein alone was insufﬁcient re-localize RCK/p54 or G3BP1
to lipid droplets (Fig. S6). Arsenite-treatment also did not
re-localize stress granule proteins to lipid droplets (data not
shown). Therefore, the re-localization of P-body and stress gran-
ule proteins to lipid droplets is not a cellular response to stress
and likely requires the expression of other HCV proteins with or
without core, and HCV RNA.
In conclusion, we ﬁnd that depletion of select P-bodies and
stress granule proteins decreases HCV gene expression. That HCV
re-localizes P-body and stress granule proteins to core protein at
lipid droplets highlights an unexpected role for these proteins in
the HCV life cycle, possibly to segregate viral RNA for HCV gene
expression or assembly.Materials and methods
Cells
Huh7 cells were maintained in DMEM and supplemented with
10% FBS, 1% nonessential amino acids and 200 mM L-glutamine.
Small interfering RNA (siRNA) transfections
All siRNA oligonucleotides were synthesized by the Stanford
Protein and Nucleic Acids facility. The siRNA sequences are as follows:
siAgo2, 50-CAGCCAGCAUCGAACAUGAUU-30; siAtaxin2, 50-AAGUGU-
GAUUUGGUACUUGAU-30; siDcp2, 50-CACGGAAACUUCAGGAUAAU-
U-30; siExo10, 50-GUUUCGAGAGAAGAUUGACAAdTdT-30; siG3BP1,
50-CAGGAAGACUUGAGGACAUUU-30; siGe-1, 50-CCGAGAGUUAAA-
GAUGUGGUU-30; siGW182, 50-GAAAUGCUCUGGUCCGCUAUU-30; si-
HuR, 50-AAGAGGCAAUUACCAGUUUCAUU-30; siLsm1, 50-GUGACAUC-
CUGGCCACCUCACUU-30; siRCK/p54, 50-GCAGAAACCCUAUGAGA-
UUUU-30; siTIA-1, 50-CUGGGCUAACAGAACAACUAAUU-30; siUpf1,
50-GAUGCAGUUCCGCUCCAUU-30; siXrn1; 50-GAGGUGUUGUUUCG-
CAUUAUU-30. Oligonucleotides were resuspended in RNase-free
water to a 50 mM ﬁnal concentration. Sense and antisense strands
were combined in annealing buffer (150mM HEPES (pH 7.4),
500 mM potassium acetate, and 10mM magnesium acetate) to a
ﬁnal concentration of 20 mM, denatured for 1 min at 95 1C, and
annealed for 1 h at 37 1C. Control RISC-free siRNA was purchased
from Dharmacon (Catalog no. D-001220-01-05).
Huh7 cells were seeded in 60 mm tissue culture plates. The
following day, Huh7 cells were transfected with 100 nM of siRNA
duplexes and Dharmafect I reagent (Dharmacon) according to the
manufacturer’s protocol. Twenty-four hours post-transfection,
cells were infected with JFH-1 virus as described, and harvested
3 days p.i. The efﬁciency of siRNA depletion was examined by
western blot analysis.
Plasmid transfections
pcDNA3.1 was purchased from Invitrogen. pcDNA-Core 191
was a generous gift from Melanie Ott (Gladstone Institute, UCSF).
Huh7 cells seeded in 8-chambered coverglass slides (LabTek II
chamber slides, Thermo Scientiﬁc) were transfected with 0.8 mg
pcDNA3.1 and Core 191 plasmids and Lipofectamine2000 reagent(Invitrogen) according to the manufacturer’s protocol. Twenty-
four hours post-transfection, the cells were ﬁxed with 4% paraf-
ormaldehyde (Electron Microscopy Sciences) in PBS, and
processed for immunoﬂuorescence analysis.
JFH-1 infections and lysate preparations
Huh7 cells were infected at 37 1C with the JFH-1 infectious
HCV virus (Wakita et al., 2005) at a multiplicity of infection (moi)
of 0.01. Five hours after infection, cells were trypsinized, and
replated in duplicate tissue culture plates. Three days p.i. cells
were harvested. For western blot analysis, cells were washed with
phosphate-buffered saline (PBS) and pelleted brieﬂy at room
temperature. Pelleted cells were lysed in RIPA buffer (100 mM
Tris–HCl (pH 7.4), 150 mM NaCl, 1% sodium deoxycholic acid, 1%
Triton X-100, and 0.1% SDS) containing Complete EDTA-free
protease inhibitors (Roche) for 20 min on ice and pelleted for
20 min at 16,000 g at 4 1C. Cell pellets prepared for examination
of eIF2a phosphorylation were lysed in RIPA buffer containing
Complete EDTA-free protease inhibitors and PhosphoSTOP
(Roche). Bradford reagent (BioRad) was used to quantitate the
protein concentration of the clariﬁed supernatants. For RNA
analysis, cells were lysed in TRIzol reagent (Invitrogen), and
RNA was isolated according to the manufacturer’s protocol.
Electroporation of HCV RNA
pH77c and pH77DE1/p7 plasmids have been previously
described (Jopling et al., 2005). HCV RNA was transcribed
in vitro from either pH77c or pH77DE1/p7 plasmids by the T7
RNA polymerase, using the Megascript kit (Ambion) according to
the manufacturer’s protocol. For electroporation, Huh7 cells were
trypsinized, sedimented at 1000 rpm for 5 min, and then washed
ﬁrst with PBS and then Cytomix buffer (120 mM KCl, 150 mM
CaCl2, 10 mM K2HPO4, 25 mM HEPES, 2 mM EDTA, and 2 mM
MgCl2; pH 7.6). Huh7 cells in Cytomix buffer were electroporated
with 10 mg of the respective HCV RNAs in a 0.4 cm Biorad cuvette
using the BioRad Genepulser Xcell. Following electroporation,
cells were allowed to recover at room temperature for 10 min,
and then seeded in 8-chambered coverglass slides (LabTek
II chamber slides, Thermo Scientiﬁc). Five days after electropora-
tion, cells were ﬁxed with 4% paraformaldehyde (Electron Micro-
scopy Sciences) in PBS, and processed for immunoﬂuorescence.
Western blot analysis
For western blot analysis, 20 mg cell lysate was mixed with 5
protein sample buffer (200 mM Tris–HCl (pH 6.8), 50% glycerol,
25% SDS and b-mercaptoethanol), denatured for 5 min at 95 1C,
and loaded onto a 8%, 10% or 12.5% polyacrylamide-SDS gel. After
electrophoresis, proteins were transferred to a PVDF membrane
(Millipore) for 1 h or 1.5 h at 4 1C at 100 V. The membranes were
blocked at room temperature for 1 h with 5% nonfat dry milk
(or bovine serum albumin) in TBS (50 mM Tris–HCl (pH 7.4), and
150 mM NaCl) with 0.1% Tween 20 (TBS/T), and then incubated
overnight at 4 1C with primary antibodies. Membranes were
washed 310 min with TBS/T prior incubating with the horse-
radish peroxidase-conjugated secondary antibodies diluted in 5%
milk/TBS/T for 1 h at room temperature. After washing 310 min
with TBS/T, bound antibodies were labeled with Pierce ECL
Western Blotting Substrate (Thermo Scientiﬁc) and detected after
exposure to Biomax Light Film (Kodak).
The following primary antibodies were used for western blot
analysis: anti-Actin (1:5,000, Sigma A2066), anti-Ago2 (1:10,
a gift from Dr. Gunter Meister), anti-Ataxin2 (1:250, BD Transduc-
tion Laboratories 611378), anti-Dcp1a (1:1000, Abcam ab57654),
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(RCK/p54) (1:5000, Bethyl Laboratories A300-460A), anti-eIF2a
(K-17) (1:1000, Santa Cruz sc-30882), anti-PM/Scl-100 (Exo10)
(1:5000, Sigma P41124), anti-G3BP1 (1:20,000, Bethyl Labora-
tories A302-034A), anti-GAPDH (1:100,000, EMD Chemicals
CB1001), anti-GW182 (1:10,000, Bethyl Laboratories A302-
329A), anti-HCV core (C7–50) (1:1000; Abcam ab2740), anti-
HCV NS5A (1:10,000; a gift from Dr. Charles Rice), anti-HuR
(ELAV1) (19F12) (1:1000, Abcam ab14371), anti-Lsm1 (1:1000,
Sigma Prestige Antibodies HPA11799), anti-Phospho eIF2a
(Ser51) (1:1000, Cell Signaling 3597), anti-RCD8 (Ge-1) (1:10,
000, Bethyl Laboratories A300-745A), anti-Rent1 (Upf1) (1:10,
000, Bethyl Laboratories A301-902A), anti-TIA-1 (C-20)( 1:2000,
Santa Cruz sc-1751), anti-TIAR (C-18) (1:2000, Santa Cruz sc-
1749), and anti-Xrn1 (1:10,000, Bethyl Laboratories A300-443A).
Donkey anti-goat-HRP (sc-2020), donkey anti-mouse-HRP (sc-
2314), donkey anti-rabbit-HRP (sc-2313) and goat anti-rat-HRP
(sc-2032) were purchased from Santa Cruz Biotechnologies and
used at 1:10,000.
To quantitiate cell-associated HCV core abundances, following
incubation with primary antibody, membranes were incubated
with goat anti-mouse and goat anti-rabbit alkaline phospatase-
conjugated antibodies (Invitrogen, 81–6522 and 81–6122) at
1:20,000. Bound antibodies were labeled with ECF substrate (GE
Life Sciences) and detected with a STORM phosphorimager.
Northern blot analysis
To visualize speciﬁc mRNAs, 10 mg TRIzol-extracted RNA was
resuspended in loading buffer (1% MOPS-EDTA-sodium acetate
(MESA), 67% formaldehyde, and 50% formamide), denatured for
10 min at 65 1C and separated in 1.2% agarose/6.7% formaldehyde
gels. Samples were separated in gels in MESA buffer, containing
18% formaldehyde, at 100 V. RNA was transferred and UV cross-
linked to a Zeta probe membrane (BioRad). Detection of HCV and
actin RNA was performed using the ExpressHyb hybridization
buffer (Clontech) and [a-32P] dATP-RadPrime DNA labeled (Invi-
trogen) probes.
To examine small RNAs, 10 mg TRIzol-extracted RNA was
resuspended in loading buffer (95% formamide, 1% EDTA), dena-
tured for 5 min at 95 1C and separated in 15% polyacrylamide-
6.75 M urea gels (Sequagel, National Diagnostics). Gels were
electrophoresed in 1 tris–borate buffer at 1,400 V, 250 mA
and 30 W for 1 h 20 min. Subsequently, RNA was transferred to
a membrane (Hybond) for 1 h at 1,400 V, 250 mA and 30 W using
Owl Semi Dry Electroblotter (Thermo Scientiﬁc). MiR-122 and U6
RNA were detected using the UltraHyb Oligo buffer (Ambion) and
oligonucleotide probes. MiR-122 and U6 oligonucleotide probes
were 50-end labeled with PNK kinase and [g-32P] dATP. Oligonu-
cleotide sequences of miR-122 and U6 probes are 50-CAAACAC-
CATTGTCACACTCCA-30 and 50-CACGAATTTGCGTGTCATCCTTGC-30
respectively.
Immunoﬂuorescence staining
Uninfected and HCV-infected Huh7 cells were grown in
8-chambered coverglass slides (LabTek II chamber slides, Thermo
Scientiﬁc) for 3 days. The cells were washed twice with PBS, and
then ﬁxed with 4% paraformaldehyde (Electron Microscopy
Sciences) in PBS at room temperature for 20 min. The cells were
again washed twice with PBS, and then permeabilized at room
temperature for 15 min with 0.5% Triton X-100 in 1% ﬁsh gelatin
(Sigma) in PBS (1% FG/PBS). Cells prepared for lipid droplet
staining were permeabilized at room temperature for 5 min with
0.1% Triton X-100 in 1% FG/PBS. After 310 min incubations with
1% FG/PBS, the cells were incubated overnight at 4 1C withprimary antibodies diluted in 1% FG/PBS. Cells were washed
210 min with 1% FG/PBS prior incubating with secondary
antibodies conjugated to ﬂuorophores for 2 h at room tempera-
ture. Cells were washed 210 min with 1% FG/PBS and then
incubated with Hoechst 33258 dye (Sigma) in 1% FG/PBS for
5 min at room temperature. After two ﬁnal 5 min washes the
coverglass slides were mounted with Fluoromount-G (South-
ernBiotech), and examined under a laser scanning confocal
microscope (Zeiss LSM 510).
The following primary antibodies were used for immunoﬂuor-
escence: anti-Dcp2 (1:800, Bethyl Laboratories A302-597A),
anti-DDX6 (RCK/p54) (1:1000, Bethyl Laboratories A300-461A),
anti-DGAT-1 (H-255) (1:50, Santa Cruz sc-32861), anti-dsRNA
(mAb J2) (1:250, Engscicons 10010200), anti-eIF3Z N20 (1:200,
Santa Cruz sc-16377), anti-PM/Scl-100 (Exo10) (1:1000, Sigma
P41124), anti-G3BP1 (1:1000, Bethyl Laboratories A302-034A),
anti-GW182 (1:1000, a gift from Dr. Marvin Friztler), anti-HCV
Core (C7–50) (1:1000, Abcam ab2740), anti-HCV NS5A (1:10,000,
a gift from Dr. Charles Rice), anti-Lsm1 (1:800, Sigma Prestige
Antibodies HPA11799), anti-RCD8 (Ge-1) (1:1000, Bethyl Labora-
tories A300-745A), anti-Rent1 (Upf1) (1:1000, Bethyl Laboratories
A301-902A), anti-TIA-1 (C-20) (1:50, Santa Cruz sc-1751), anti-
TIAR (C-18) (1:50, Santa Cruz sc-1749) and anti-Xrn1 (1:800,
Bethyl Laboratories A300-443A). Secondary antibodies were used
at 1:200. Bodipy 493/503 (1 mg/ml, D3922 ) and donkey anti-
Goat AlexaFluor647 (A2144), donkey anti-Mouse AlexaFlour488
(A21202), donkey anti-Mouse AlexaFluor594 (A21203), donkey
anti-Rabbit AlexaFluor594 (A21207) and donkey anti-Rabbit
AlexaFluor647 (A31573) were purchased from Invitrogen. Sheep
anti-Human-TRITC (ab6867) was purchased from Abcam.
Infectivity assays
A previously described limiting dilution assay was used to
determine the infectivity of extracellular and cell-associated JFH-
1 virus (Lindenbach et al., 2005). Brieﬂy, P-body and stress
granule proteins were depleted and cells infected with JFH-1.
Infected cells were seeded into 60 mm tissue culture plates, and
extracellular virus was collected at 3 days pi. Cell-associated virus
was harvested by washing the cell monolayer twice with PBS, and
then adding 1 ml media to each plate. Plates were scraped and
cells collected. Extracellular and cell-associated virus was freeze-
thawed once, and cell debris removed by a brief high-speed spin.
Infectivity was determined by a TCID50 assay. Infected cells were
detected using the mouse monoclonal HCV Core-speciﬁc antibody
C7–50 (Abcam) incubated at 1:2000 at 4 1C overnight, and
AlexaFluor488-conjugated goat anti-mouse antibody (Invitrogen)
incubated at 1:500 at room temperature for 2 h, and the TCID50
calculated. The infectivity of extracellular and cell-associated
virus was assayed in parallel.
HCV Core antigen ELISA
Quantitiation of extracellular core was assayed with the
Quicktiter Core Antigen ELISA kit (Cell Biolabs, Inc) according to
the manufacturer’s instructions.
Quantitation of P-body foci and stress granules, and co-localization
Ten images were captured with a laser scanning Zeiss LSM5
confocal microscope. P-body foci and stress granules were visua-
lized after staining of RCK/p54 and eIF3 proteins, respectively.
The number of P-bodies and stress granules in uninfected and
JFH-1 infected cells 1, 2 and 3 days p.i. was quantiﬁed with ImageJ
as described previously (Buchan et al., 2010). The quantitation of
co-localization between core and P-body and stress granule
C.T. Pager et al. / Virology 435 (2013) 472–484 483proteins, and lipid droplets stained with Bodipy 493/503 was
determined using the Pearson’s correlation cofﬁecient (r) (Adler
and Parmryd, 2010). Pearson’s coefﬁcient ranges from þ1 (strong
correlation) to 0 (weak to no correlation) to 1 (no correlation).
Immunoﬂuorescence images were opened in ImageJ using the
LSM toolbox and the degree of co-localization examined with the
Just Another Colocalization Plugin (JACoP) (Bolte and Cordelieres,
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